免疫塞马福林与严重肌痛性肌痛症之间的关系
Dilcan Kotan1, Esen Çiçekli2, Özlem Aydemir3
1Neurology Department, Sakarya University Faculty of Medicine, Sakarya, Turkey.
Brain and behavior
|February 28, 2026
概括
免疫塞马福林水平,特别是塞马福林4A和7A,显示出潜在的生物标志物用于诊断肌痛性严重性肌痛症 (MG). 虽然在MG患者中,semaphorin 4A较低,semaphorin 7A较高,但疾病阶段与水平没有相关性.
科学领域:
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
- 生物标志物发现发现
背景情况:
- 骨髓灰质炎 (MG) 是一种自身免疫性疾病,涉及复杂的免疫系统.
- 塞马福林越来越多地被认为是各种自身免疫性疾病中的潜在生物标志物.
研究的目的:
- 为了研究特定的免疫血红素 (3A,3F,4A,4D,7A) 在肌痛性骨髓灰质炎的诊断和预后作用.
- 评估semaphorins作为MG的潜在生物标志物.
主要方法:
- 在41名MG患者和39名健康对照人群中测量了血清塞马福林水平.
- 患者根据每日生活中的Myasthenia Gravis活动量表进行了分层.
- 分析了与疾病状况相关的塞马福林水平.
主要成果:
- 与对照人群相比,MG患者的血红素4A水平显著下降.
- 与对照组相比,MG患者的Semaforin 7A水平显著升高.
- 没有观察到血红素水平和MG疾病阶段之间的显著相关性.
结论:
- 血红素4A和7A水平可以作为MG的诊断或差异诊断标记.
- 这些发现可以为开发针对自身免疫性疾病中的semaphorin通路的新疗法提供信息.
关键词:
肌痛性骨髓灰质炎 (Myasthenia Gravis) 是一个严重的疾病.半氨酸3A 半氨酸3A 半氨酸3A半氨酸3F 3F是什么意思塞马福林4A 4A 是一个塞马福林 4D 是一个半氨酸7A 7A的时间更多相关视频
04:30Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models
Published on: March 8, 2024
1.7K
12:18The Neuromuscular Junction: Measuring Synapse Size, Fragmentation and Changes in Synaptic Protein Density Using Confocal Fluorescence Microscopy
Published on: December 26, 2014
22.8K
相关概念视频
Myasthenia Gravis: Overview and Treatment
3.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.1K
Myasthenia Gravis: Diagnostic Tests
2.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.8K
Chemical Synapses
12.1K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.1K
Chemical Synapses
5.2K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
5.2K
Disorders of the Skeletal Muscle
2.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.1K
Muscle Contraction
9.1K
In skeletal muscles, acetylcholine is released by nerve terminals at the motor endplate—the point of synaptic communication between motor neurons and muscle fibers. The binding of acetylcholine to its receptors on the sarcolemma allows entry of sodium ions into the cell and triggers an action potential in the muscle cell. Thus, electrical signals from the brain are transmitted to the muscle. Subsequently, the enzyme acetylcholinesterase breaks down acetylcholine to prevent excessive...
9.1K
